Articles

A1C Translation to Estimated Average Glucose (eAG) Units Will Yield Easier Patient Education. New more accurate formula used to convert A1c to average blood glucose.

The world’s largest diabetes trial has shown intensive blood glucose can reduce the risk of kidney disease by 21% with no evidence of any increased risk of death when blood glucose was intensively controlled.

A major 7.5 year long-term U.S. clinical trial to study whether intense control of blood glucose in type 2 diabetes would reduce the risk of cardiovascular disease found a reduction in cardiovascular events, but it was not statistically significant, according to a report presented at the American Diabetes Association’s 68th Annual …

For the first time a previously unrecognized harm due to a strategy of intensified glucose lowering in high risk patients with type 2 diabetes has been identified, according to a report at the American Diabetes Association’s 68th Annual Scientific Sessions.

Favorable 5-Year Outcome for Asymptomatic People with Type 2 Without Evidence of Coronary Artery Disease. Expensive Screening Not Needed When Standard Clinical Care and Follow-Up Attentive

New studies show GlycoMark may be a more effective monitor than A1c of exenatide, sitagliptin, pramlintide and prandaial insulin thereapies in certain diabetic populations.

InteKrin Therapeutics Presented Phase 2a Data INT131, a non-TZD SPPARM

Results from a 24-week Phase III study showed that saxagliptin, a selective, reversible inhibitor of the dipeptidyl peptidase (DPP-4) enzyme in development by Bristol-Myers Squibb Company and AstraZeneca produced significant reductions in key measures of glucose control, A1C, FPG and PPG in treatment naïve people with type 2 diabetes compared …

We often have heard that Levemir has to be high dose to have the same 24 hour effect as Lantus. Now a new head to head study dispels that rumor. It appears that Detimir can be used once-daily and have a comparable blood glucose response to insulin glargine over a 24-hour period …

The ties being found between type 2 diabetes and obstructive sleep apnea (OSA) indicate these disorders have major implications on public health.